Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by GolongGekko


TRVN

Adan Feurerstein on TRVN - The STREET

A novel, intravenous opioid developed by Trevena (TRVN) provided...

February 25, 2017

TRVN

TRVN Buzz - FYI

Analysts and the market have a different view on a small cap biopharma...

February 25, 2017

TRVN

Major Holders - TRVN - FYI

Major Holders Currency in USD Breakdown 35...

February 24, 2017

TRVN

Let's see if this occurs...

poponetime   $TRVN this will be $4.50 Premarket tomorrow a.m prior...

February 22, 2017

TRVN

Allergan has history with TRVN...

Allergan's Saunders: No interest in Valeant Feb. 22, 2017 6:49 PM...

February 22, 2017

TRVN

Buyers of Trevena on Share Weakness - Aegis

  Julie Lamb, Editor-February 22, 2017, 11:33 AM EDT    ...

February 22, 2017

T.IAE

RE:RE:RE:RE:RE:RE:Still Very Quiet

NEVER bet against the GEKKO! GOLONG and PROSPER!!! It would appear that the...

February 21, 2017

TRVN

Olinvo Remains Commercially Viable

  Jason Cohen, Editor-February 21, 2017, 7:53 PM EDT SHARE ON...

February 21, 2017

TRVN

Maxine Gowen, Ph.D., chief executive officer

“We believe the data for all three dose regimens will support FDA approval of...

February 21, 2017

TRVN

Ouch! Short Squeeze Full Tilt...

Listen to the TRVN 58 minute presentation and Analyst questions. This is...

February 21, 2017

T.IAE

RE:RE:Where is the OSC when you need them....asleep ?

That is in everyone's best interest.  That is the correct and fair...

February 19, 2017

TRVN

CNBC on Oliceridine - FYI

Oliceridine: A breakthrough therapy for hospital patients Oliceridine...

February 17, 2017

TRVN

Trevena Due Diligence - FYI

Trevena Due Diligence  READ THE DUE DILIGENCE FIRST. If you make an...

February 17, 2017

TRVN

FYI from Seeking Alpha...

As someone who specializes in nano to small-cap biotech, I rarely advocate a...

February 17, 2017

TRVN

CARA vs TRVN . . .

Interesting comparison with these two Bio plays.  Very similar in...

February 17, 2017

T.IAE

Kehsho . . .Check PM (eom)

Best GG

February 17, 2017

TRVN

Institutional BUYING - FYI

A number of institutional investors have recently modified their holdings of...

February 16, 2017

TRVN

Yahoo Chat - FYI

Peter W wrote about TRVN... Be patient. TRVN clinical study is complete...

February 16, 2017

TRVN

Bio Market Jitters?? -FYI

U.S. President Donald Trump's vow to roll back government regulations at...

February 16, 2017

TRVN

3- Month SP Pattern...

Also appears that TRVN is quite Volitile going UP as well a selling DOWN...

February 16, 2017